Skip to main content
Have a personal or library account? Click to login
Detection of Epstein-Barr virus among chronic kidney disease patients in Najaf, Iraq Cover

Detection of Epstein-Barr virus among chronic kidney disease patients in Najaf, Iraq

By:  and    
Open Access
|Apr 2024

References

  1. Farrell PJ. Epstein-Barr virus and cancer. Annu Rev Pathol Mech Dis. 2019;14:29-53.
  2. Mui UN, Haley CT, Tyring SK. Viral oncology: Molecular biology and pathogenesis. J Clin Med. 2017;6(111):1-58.
  3. Rezk SA, Zhao X, Weiss MD. Epstein-Barr virus (EBV) – associated lymphoid proliferations, a 2018 update. Human Pathol. 2018;79: 18-41.
  4. Cohen JI, Wang F, Mannick J, Kieff E. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. PNAS. 1989;86(23):9558-62.
  5. Schlee M, Krug T, Gires O, Zeidler R. Hammerschmidt W, Mailhammer R, et al. Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV. J Virol. 2004;78(8):3941-52.
  6. Gordadze AV, Poston D, Ling PD. The EBNA2 polyproline region is dispensable for Epstein-Barr virus-mediated immortalization maintenance. J Virol. 2002;76(14):7349-55.
  7. Kempkes B, Ling PD. EBNA2 and its coactivator EBNA-LP. Curr Top Microbiol Immunol. 2015:391:35-59.
  8. Zimber-Strobl U, Strobl LJ. EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes. Semin Cancer Biol. 2001;11(6):423-34.
  9. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer. 2004;4(10):757-68.
  10. Tzellos S, Farrell PJ. Epstein-Barr virus sequence variation – biology and disease. Pathogens. 2012;1(2):156-75.
  11. Redha AQ, Al-Obaidi AB, Ghazi HF, Kadhim HS. Sero – prevalence and plasma viral load of Epstein-Barr virus among Iraqi blood donors. Iraqi JMS. 2017;15(2):135-42.
  12. López-Valencia D, Medina-Ortega Á, Hoyos-Samboní DF, Saavedra-Torres JS, Salguero C. Epstein-Barr virus infection as a predisposing factor for multiple sclerosis. An update from molecular biology, immunology and epidemiology. Rev Fac Med. 2019;67(3):493-501.
  13. Pagano JS. Is Epstein-Barr virus transmitted sexually? J Infect Dis. 2007;195(4):469-70.
  14. Sitki-Green D, Covington M, Raab-Traub N. Compartmentalization and transmission of multiple Epstein-Barr virus strains in asymptomatic carriers. J Virol. 2003;77(3):1840-7.
  15. Abecassis M, Bartlett ST, Collins AJ, Davis CL, Delmonico FL, Friedewald JJ, et al. Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQI™) conference. Clin J Am Soc Nephrol. 2008;3(2):471-80.
  16. Yasir SJ, Marzoq HS. (2022, January). Detection of Epstein-Barr virus in hemodialysis cases in Al-Najaf governorate. AIP Conf Proc. 2022;2386(1):020020.
  17. Al-Azzawy MA, Tawfiq SK, Qader SM. Detection of EBV and CMV coinfection among patients under hemodialysis. Int J Health Sci. 2022;(II):4456-63.
  18. Carvalho ADAT, Perez MDMC, Martins MECC, Dasilva ICG, Oliveira CCMX, Gueiros LAM, et al. Detection of viral load of Epstein-Barr virus and Cytomegalovirus by a polymerase chain reaction in patients with chronic kidney disease. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;129(1):152-3.
  19. El Mashad N, Refaie A, Mofreh M, Salah HH, Zaki ME. Comparison between serological and molecular diagnosis of Epstein-Barr virus infection among Egyptian renal transplant recipients. Egypt J Hosp Med. 2022;89(2):7103-11.
  20. Abusalah MAH, Gan SH, Al-Hatamleh MA, Irekeola AA, Shueb RH, Yean Yean C. Recent advances in diagnostic approaches for Epstein-Barr virus. Pathogens. 2020;9(3):226.
  21. Chen C, Huang AK, Shen JH, Tsao K, Huang Y. A large-scale seroprevalence of Epstein-Barr virus in Taiwan. PLoS ONE. 2015;10(1):1-11.
  22. Aboud RS, Fadhil HY. Evaluation of anti-Epstien-Barr Virus antibodies in female patients with autoimmune hepatitis type-1. J Biotechnol Resea Cent. 2015;9(1):52-6.
  23. Shams-Aldein SA, Abdlameer AS, Al-Obaidi AB, Kadhim HS, Al-Saedi AJ. Detection of Epstein-Barr virus in renal transplant recipients: Two centers study. Iraqi J Med Sci. 2015;13(2).
  24. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res. 1996;6(10):986-94.
  25. Delgado R, Lumbreras C, Alba C, Pedraza MA, Otero JR, Gomez R, et al. Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients. J Clin Microbiol. 1992;30(7):1876-8.
  26. Riddler SA, Breinig MC, McKnight JL. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood. 1994;84(3):972-84.
  27. Rasool S, Pampori RA. Majid S, Wani H, Farooq R, Patigaroo S. Comparison between ELISA and PCR for detection of Epstein-Barr virus in head and neck malignancies. IJHNS. 2020;11(1):6-11.
  28. Al Sidairi H, Binkhamis K, Jackson C, Roberts C, Heinstein C, MacDonald J, et al. Comparison of two automated instruments for Epstein-Barr virus serology in a large adult hospital and implementation of an Epstein-Barr virus nuclear antigen-based testing algorithm. J Med Microbiol. 2017;66(11):1628-34.
  29. De Paschale M, Clerici P. Serological diagnosis of Epstein-Barr virus infection: problems and solutions. World J Virol. 2012;1(1):31-43.
  30. Enan KA, Rennert H, El-Eragi AM, El Hussein ARM, Elkhidir IM. (2011). Comparison of Real-time PCR to ELISA for the detection of human cytomegalovirus infection in renal transplant patients in the Sudan. Virol J. 2011;8:1-4.
  31. Pavšič J, Devonshire AS, Parkes H, Schimmel H, Foy CA, Karczmarczyk M, et al. (2015). Standardization of nucleic acid tests for clinical measurements of bacteria and viruses. J Clin Microbiol. 2015;53(7):2008-14.
  32. Hasannia T, Moosavi Movahed SM, Vakili R, Rafatpanah H, Hekmat R, Valizadeh N, Rezaee SA. Active CMV and EBV infections in renal transplant recipients with unexplained fever and elevated serum creatinine. Ren Fail. 2016;38(9):1418-24.
  33. Samiei RN, Mahmoudvand S, Shokri S, Makvandi M, Shahbazian H, Pirmoradi R, Nowrozi S. (2019). The frequency of Epstein-Barr virus among hemodialysis patients, Ahvaz, Iran. Iranian J Microbiol. 2019;11(1):75.
  34. Ad’hiah AH, Atiyah NS, Fadhil HY. (2023). Qualitative and Quantitative Molecular Analysis of Epstein-Barr Virus in Iraqi Patients with Relapsing-Remitting Multiple Sclerosis. Iraqi J Sci. 2023; 127-137.
DOI: https://doi.org/10.2478/cipms-2024-0008 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Language: English
Page range: 47 - 51
Submitted on: Jun 21, 2023
Accepted on: Sep 9, 2023
Published online: Apr 11, 2024
Published in print: Mar 1, 2024
Published by: Sciendo
In partnership with: Paradigm Publishing Services

© 2024 Zahraa Basem, Huda Jameel, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.